MX2023008072A - Metodo para la evaluacion y el tratamiento de la celulitis. - Google Patents

Metodo para la evaluacion y el tratamiento de la celulitis.

Info

Publication number
MX2023008072A
MX2023008072A MX2023008072A MX2023008072A MX2023008072A MX 2023008072 A MX2023008072 A MX 2023008072A MX 2023008072 A MX2023008072 A MX 2023008072A MX 2023008072 A MX2023008072 A MX 2023008072A MX 2023008072 A MX2023008072 A MX 2023008072A
Authority
MX
Mexico
Prior art keywords
assessing
treating cellulite
physician
patient
cellulite
Prior art date
Application number
MX2023008072A
Other languages
English (en)
Spanish (es)
Inventor
Michael Mclane
Jeffrey Davidson
Genzhou Liu
Original Assignee
Endo Ventures Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Ventures Ltd filed Critical Endo Ventures Ltd
Publication of MX2023008072A publication Critical patent/MX2023008072A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/444Evaluating skin marks, e.g. mole, nevi, tumour, scar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4848Monitoring or testing the effects of treatment, e.g. of medication
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886Metalloendopeptidases (3.4.24), e.g. collagenase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24003Microbial collagenase (3.4.24.3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1079Measuring physical dimensions, e.g. size of the entire body or parts thereof using optical or photographic means

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
MX2023008072A 2017-03-01 2019-09-02 Metodo para la evaluacion y el tratamiento de la celulitis. MX2023008072A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762465622P 2017-03-01 2017-03-01
US201762485705P 2017-04-14 2017-04-14
US201762607188P 2017-12-18 2017-12-18

Publications (1)

Publication Number Publication Date
MX2023008072A true MX2023008072A (es) 2023-07-17

Family

ID=61768443

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2023008072A MX2023008072A (es) 2017-03-01 2019-09-02 Metodo para la evaluacion y el tratamiento de la celulitis.
MX2023015506A MX2023015506A (es) 2017-03-01 2019-09-02 Metodo para la evaluacion y el tratamiento de la celulitis.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023015506A MX2023015506A (es) 2017-03-01 2019-09-02 Metodo para la evaluacion y el tratamiento de la celulitis.

Country Status (18)

Country Link
US (4) US11123280B2 (enExample)
EP (2) EP4591945A2 (enExample)
JP (2) JP7558654B2 (enExample)
KR (3) KR20230003601A (enExample)
CN (2) CN110545722B (enExample)
AU (4) AU2018226820B2 (enExample)
BR (1) BR112019018277A2 (enExample)
CA (1) CA3055041A1 (enExample)
DK (1) DK3589204T3 (enExample)
ES (1) ES3036011T3 (enExample)
FI (1) FI3589204T3 (enExample)
HU (1) HUE072115T2 (enExample)
IL (2) IL301796A (enExample)
MX (2) MX2023008072A (enExample)
NZ (1) NZ756787A (enExample)
PL (1) PL3589204T3 (enExample)
PT (1) PT3589204T (enExample)
WO (1) WO2018160905A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2861033C (en) 2012-01-12 2017-07-25 Auxilium International Holdings, Inc. Clostridium histolyticum enzymes and methods for the use thereof
KR20230003601A (ko) 2017-03-01 2023-01-06 엔도 벤쳐즈 리미티드 셀룰라이트를 평가하고 치료하기 위한 장치 및 방법
CN118325876A (zh) 2017-03-28 2024-07-12 恩多风投有限公司 生产胶原酶的改进方法
WO2020021332A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020021330A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
KR20210079291A (ko) 2018-09-18 2021-06-29 엔도 글로벌 에스테틱스 리미티드 셀룰라이트를 치료하기 위한 조성물 및 방법
US20220305094A1 (en) 2019-01-06 2022-09-29 Endo Global Aesthetics Limited Collagenase formulations and methods of producing the same
US11432733B2 (en) 2019-03-13 2022-09-06 Blossom Innovations Tissue detection devices, systems and methods
IL311679A (en) 2019-03-13 2024-05-01 Blossom Innovations Llc Devices, systems and methods for tissue analysis, positioning and treatments using optical radiation.
US20220095925A1 (en) 2019-03-13 2022-03-31 Blossom Innovations, LLC Devices, systems and methods for tissue analysis, location determination and therapy thereof using optical radiation
CN113033528A (zh) * 2021-05-27 2021-06-25 明品云(北京)数据科技有限公司 一种反馈量表评估方法、系统、设备和介质

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821364A (en) 1966-07-08 1974-06-28 Advance Biofactures Corp Process of producing collagenase
JPS5662229A (en) 1979-10-25 1981-05-28 Asahi Glass Co Ltd Electro-optical dimming panel
US4338300A (en) 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
WO1984002653A1 (fr) 1983-01-05 1984-07-19 Pasteur Institut Preparation a activite collagenolytique ayant une activite elevee et compositions pharmaceutiques la contenant
US4524065A (en) 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US4645668A (en) 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US5252461A (en) 1990-05-01 1993-10-12 The Regents Of The Univ. Of California Mixed immunoglobulins for detection of rheumatoid factors
CA2047306A1 (en) 1990-07-23 1992-01-24 Milan Holjevac Mutant bacterium clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase
US5393792A (en) 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5462739A (en) 1991-11-21 1995-10-31 Yeda Research And Development Co., Ltd. Microdelivery device and method for enhanced drug administration to the eye
US5256140A (en) 1992-03-27 1993-10-26 Fallien Cosmeceuticals, Ltd. Composition for levelling skin
CA2138948A1 (en) 1992-06-22 1994-01-06 Hun-Chi Lin Molecular cloning of the genes responsible for collagenase production from clostridium histolyticum
JP3186881B2 (ja) 1993-02-18 2001-07-11 倉敷紡績株式会社 肝細胞の分離方法
US5332503A (en) 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
JP3028852B2 (ja) 1994-06-24 2000-04-04 ロシュ ダイアグノスティックス コーポレーション ヒストリチクス菌から得られるコラゲナーゼおよび2つの他のプロテアーゼの精製混合物
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase
CA2158822C (en) 1994-09-27 2008-12-23 Kusuki Nishioka Therapeutic agent for rheumatic disease
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
PL322271A1 (en) 1995-03-16 1998-01-19 Knoll Ag Novel defined mixtures of enzymes for use in growing cells and healing wounds
IT1279011B1 (it) 1995-06-15 1997-12-02 Ips Int Prod Services Apparecchiatura per la rilevazione e scelta dei trattamenti della cellulite
US5705170A (en) * 1995-10-24 1998-01-06 Plantech International, Inc. Herbal cellulite treatments
US5989888A (en) 1996-01-24 1999-11-23 Roche Diagnostics Corporation Purified mixture of collagenase I, collagenase II and two other proteases
WO1998022574A2 (de) 1996-11-19 1998-05-28 Roche Diagnostics Gmbh Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
US5830741A (en) 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US5753785A (en) 1996-12-16 1998-05-19 Fina Technology, Inc. Production of E-B copolymers with a single metallocene catalyst and a single monomer
US6086872A (en) 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
JPH10262658A (ja) 1997-03-28 1998-10-06 Kikkoman Corp ザルコシン・オキシダーゼの結晶、その製造方法及び三次元構造
TR200001789T2 (tr) 1997-10-03 2000-10-23 Lavipharm Laboratories, Inc. Prolamin-bitki kutuplu lipit kompozisyonu, bunun hazırlama ve uygulama metodu
GB9724802D0 (en) 1997-11-24 1998-01-21 Unilever Plc Antiperspirant or deodorant compoistions
US20020036328A1 (en) 1998-11-16 2002-03-28 William R. Richards, Jr. Offset drain fermi-threshold field effect transistors
FR2788682B1 (fr) * 1999-01-26 2001-04-06 Seb Sa Dispositif de thermographie
US6022539A (en) 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
RU2180002C2 (ru) 1999-08-16 2002-02-27 Пермское научно-производственное объединение "Биомед" Способ получения коллагеназы
US6358539B1 (en) 1999-08-20 2002-03-19 Howard Murad Pharmaceutical compositions for reducing the appearance of cellulite
US6280993B1 (en) 1999-08-24 2001-08-28 Ichiro Yamato Gene encoding class I collagenase
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
DK1220830T3 (da) 1999-09-24 2007-07-16 Proteon Therapeutics Inc Anvendelse af elastase til åbning af obstruerede arterier og vener
EP1187602A4 (en) 2000-04-18 2004-09-15 Peptron Inc SUSTAINABLE RELEASE INJECTABLE PHARMACEUTICAL COMPOSITION AND METHODS OF PREPARING THE SAME
EP1355566B1 (en) 2000-12-18 2012-11-28 Board Of Regents, The University Of Texas System Local regional chemotherapy and radiotherapy using in situ hydrogel
WO2002060410A2 (en) 2001-01-30 2002-08-08 The Regents Of The University Of Michigan Methods for sustained release local delivery of drugs for ablation of unwanted tissue
ATE302844T1 (de) 2001-07-02 2005-09-15 Nordmark Arzneimittel Gmbh & C Verfahren zur aufreinigung eines enzyms und hiernach hergestelltes, aufgereinigtes enzym sowie verwendung des enzyms
GB0124124D0 (en) 2001-10-08 2001-11-28 Medical Res Council Methods of treatment
ES2300569T3 (es) * 2002-03-15 2008-06-16 The General Hospital Corporation Dispositivos para la perturbacion selectiva de tejido graso mediante enfriamiento controlado.
JP2003284553A (ja) 2002-03-28 2003-10-07 Seikagaku Kogyo Co Ltd 生理活性タンパク質
EP1538980B1 (en) * 2002-06-25 2017-01-18 Ultrashape Ltd. Device for body aesthetics
EP1433845A1 (en) 2002-12-23 2004-06-30 Georg-August-Universität Clostridium tetani collagenase and uses thereof
EP1462519A1 (en) 2003-03-24 2004-09-29 Boehringer Ingelheim Austria GmbH Method and devices for producing biomolecules
JP4205496B2 (ja) 2003-06-19 2009-01-07 三菱化学株式会社 新規カルボニル還元酵素及びこれをコードするdna、ならびにこれらを利用した光学活性アルコールの製造方法
NZ576986A (en) 2004-01-30 2010-12-24 Shire Pharmaceuticals Ireland Ltd Production and purification of recombinant arylsulfatase A
US8147428B2 (en) * 2004-04-16 2012-04-03 University Of Massachusetts Device and method for quantifying edema
SI2422789T1 (en) 2004-05-19 2018-07-31 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Injectable coposition comprising sodium deoxycholate
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US7355027B2 (en) 2004-06-16 2008-04-08 Dynport Vaccine Company Llc Bacillus anthracis protective antigen
SI1781697T1 (sl) 2004-07-07 2009-08-31 Lundbeck & Co As H Novi karbamilirani epo in postopek za njegovo izdelavo
EP1773400A2 (en) 2004-07-08 2007-04-18 Amgen Inc. Therapeutic peptides
CN101010274B (zh) 2004-08-30 2012-09-05 大赛璐化学工业株式会社 聚甘油单醚及其制造方法
US20150025420A1 (en) * 2004-10-06 2015-01-22 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
DE102004060075A1 (de) 2004-12-14 2006-07-06 Merck Patent Gmbh Verfahren zur Herstellung von Onium-Salzen mit Dialkylphosphat-, Dialkylphosphinat oder (O-Alkyl)-alkyl- oder Alkyl-phosphonat-Anionen mit geringem Halogenid-Gehalt
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
KR20090130158A (ko) 2005-01-21 2009-12-17 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 유착 관절낭염을 치료하는 방법
US7854929B2 (en) 2005-01-21 2010-12-21 The Research Foundation Of State University Of New York Method for treating lateral epicondylitis using collagenase
JP2006254876A (ja) 2005-03-18 2006-09-28 Hokkaido Univ L−トリプトファン製造法
US20060251581A1 (en) 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
US20070003541A1 (en) 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
JP3122177U (ja) * 2005-09-28 2006-06-08 株式会社資生堂 セルライトの診断基準シート
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2007100590A2 (en) * 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite
US20100015262A1 (en) * 2006-03-31 2010-01-21 Regina Goralczyk Novel use of compounds and combinations of compounds for improving the physical appearance
WO2008100833A2 (en) 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
US8617543B2 (en) 2007-02-14 2013-12-31 Yolare Pharmaceuticals, LLC Modified mutant collagenase and its use in fat melting and in scar reduction
MX2009012042A (es) * 2007-05-11 2009-12-01 Sigma Tau Ind Farmaceuti Gel util para el suministro de ingredientes activos cosmeticos.
US9987221B2 (en) 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
WO2009059379A1 (en) 2007-11-07 2009-05-14 Dynamic Microbials Limited Antimicrobial compositions, formulations and uses thereof
US20100159564A1 (en) 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
ES2388219T3 (es) 2008-06-02 2012-10-10 F. Hoffmann-La Roche Ag Purificación mejorada de colagenasas a partir de un cultivo líquido de Clostridium histolyticum
US8236356B2 (en) 2008-06-11 2012-08-07 Roche Diagnostics Operations, Inc. Growth medium for Clostridium histolyticum
JP5421366B2 (ja) 2008-07-21 2014-02-19 オトノミ―,インク. 制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法
US8380531B2 (en) 2008-07-25 2013-02-19 Invivodata, Inc. Clinical trial endpoint development process
EP2369956A1 (en) 2008-10-22 2011-10-05 Allergan, Inc. Clinical assessment scales and methods
AU2009315771A1 (en) * 2008-11-11 2010-05-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
EP2363461B1 (en) 2008-11-19 2014-12-24 Meiji Seika Pharma Co., Ltd. Fusion collagenase to which affinity tag is attached, and method for producing same
IT1397646B1 (it) 2009-12-15 2013-01-18 Seidita Collagenasi ricombinanti di c. histolyticum e metodo per la loro produzione.
US9132199B2 (en) 2010-03-05 2015-09-15 University of Pittsburgh—of the Commonwealth System of Higher Education Reverse thermal gels and uses therefor
WO2011130537A2 (en) 2010-04-14 2011-10-20 Northwestern University Pharmaceutical compositions and methods for digesting atherosclerotic plaques
EP2605702A4 (en) * 2010-08-19 2014-09-17 Medicis Pharmaceutical Corp FACIAL SYSTEM AESTHETIC SCALING SYSTEM AND CORRESPONDING METHOD
US20130217789A1 (en) 2010-09-03 2013-08-22 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
US20120237492A1 (en) * 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
TWI461214B (zh) 2011-06-13 2014-11-21 Univ Chang Gung Biodegradable water-sensitive glue, a drug delivery system as a carrier thereof, and a pharmaceutical composition for the treatment and / or prevention of eye diseases
US9333005B2 (en) * 2011-10-17 2016-05-10 Sound Surgical Technologies Llc Ultrasonic probe for treating cellulite
EP3581199B1 (en) * 2011-10-21 2023-05-31 Endo Global Ventures Methods of treatment or reduction of edematous-fibrosclerotic panniculopathy
CA2861033C (en) 2012-01-12 2017-07-25 Auxilium International Holdings, Inc. Clostridium histolyticum enzymes and methods for the use thereof
JP2015506247A (ja) * 2012-01-27 2015-03-02 ルバンス セラピュティックス インク.Revance Therapeutics,Inc. 皺重症度を測定するための方法及び評価スケール
JP6049862B2 (ja) * 2012-09-07 2016-12-21 株式会社 資生堂 フィブリン3及び/又はサルコグリカンγを指標としたセルライトの評価方法及びセルライト効果薬剤の評価方法
US20160000890A1 (en) 2013-03-15 2016-01-07 Biospecifics Technologies Corp. Thermosensitive hydrogel collagenase formulations
KR102267689B1 (ko) * 2013-03-15 2021-06-22 마리 케이 인코포레이티드 화장품 조성물들 및 이의 용도
EP2968484B1 (en) 2013-03-15 2020-11-25 BioSpecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
KR102146667B1 (ko) * 2014-06-27 2020-08-21 (주)메디톡스 지방 감소를 위한 담즙산 및 염의 방법 및 조성물
CA3013776A1 (en) 2016-02-08 2017-08-17 OutcomeMD, Inc. Determining a wellness, improvement, or effectiveness score
EP3532008B1 (en) * 2016-10-28 2021-08-11 Merz Pharma GmbH & Co. KGaA The cosmetic treatment of cellulite
KR20230003601A (ko) 2017-03-01 2023-01-06 엔도 벤쳐즈 리미티드 셀룰라이트를 평가하고 치료하기 위한 장치 및 방법
CN118325876A (zh) 2017-03-28 2024-07-12 恩多风投有限公司 生产胶原酶的改进方法

Also Published As

Publication number Publication date
MX2023015506A (es) 2024-01-22
KR20190126341A (ko) 2019-11-11
DK3589204T3 (da) 2025-06-30
JP2023120246A (ja) 2023-08-29
US20250352450A1 (en) 2025-11-20
CN110545722B (zh) 2023-02-03
AU2024201429B2 (en) 2025-04-24
IL301796A (en) 2023-05-01
FI3589204T3 (fi) 2025-07-03
KR20250021648A (ko) 2025-02-13
PT3589204T (pt) 2025-07-18
AU2018226820B2 (en) 2022-12-08
JP2020511284A (ja) 2020-04-16
BR112019018277A2 (pt) 2020-06-30
US20180250217A1 (en) 2018-09-06
JP7558654B2 (ja) 2024-10-01
US20240041744A1 (en) 2024-02-08
EP3589204B1 (en) 2025-04-16
CN115969318A (zh) 2023-04-18
HUE072115T2 (hu) 2025-10-28
AU2025206433A1 (en) 2025-08-07
CA3055041A1 (en) 2018-09-07
KR20230003601A (ko) 2023-01-06
NZ756787A (en) 2025-08-29
AU2024201429A1 (en) 2024-03-21
WO2018160905A1 (en) 2018-09-07
US12403081B2 (en) 2025-09-02
EP4591945A2 (en) 2025-07-30
PL3589204T3 (pl) 2025-08-11
US11123280B2 (en) 2021-09-21
EP3589204A1 (en) 2020-01-08
AU2018226820A1 (en) 2019-09-19
IL268985A (en) 2019-10-31
AU2022271390B2 (en) 2024-01-18
AU2022271390A1 (en) 2022-12-15
US20210386644A1 (en) 2021-12-16
ES3036011T3 (en) 2025-09-11
KR102610801B1 (ko) 2023-12-05
US11813347B2 (en) 2023-11-14
CN110545722A (zh) 2019-12-06

Similar Documents

Publication Publication Date Title
MX2023008072A (es) Metodo para la evaluacion y el tratamiento de la celulitis.
SG11202100640QA (en) Blockchain transaction method and apparatus
ZA201905520B (en) Blockchain-based transaction processing method and apparatus
SG11202004839XA (en) Blockchain-based transaction processing method and apparatus
AU363694S (en) Cover for an electronic device
AU363976S (en) Cover for an electronic device
GB2548243B (en) Method(s) and apparatus for treating waste
PT3244819T (pt) Dispositivo para o tratamento cosmético de manchas cutâneas castanhas por criogenia
SG11202100493SA (en) Transaction processing method and apparatus
GB201700816D0 (en) Method and computing processing apparatus
SG11202000878RA (en) Treatment apparatus and treatment method for hardness component-containing water
GB201708654D0 (en) Apparatus and process for neuromuscular stimulation
IL246889B (en) A method for measuring engagement
PL3653759T3 (pl) Blacha cienka ze stali elektrotechnicznej o ziarnach zorientowanych i sposób jej wytwarzania
SG11201606348VA (en) Scale removal method and scale removal agent for steam generating facilities
TN2018000197A1 (en) Compositions and methods for assessing the risk of cancer occurrence
MX2016009537A (es) Metodo para tratar ropa.
MX2019002778A (es) Procedimiento de hidrogenacion.
SG11202101850QA (en) An apparatus system and method to extract minerals and metals from water
PT3498390T (pt) Aparelho de endireitamento para produtos de metal e método para substituir pelo menos um rolo de endireitamento do referido aparelho
GB2548387B (en) An apparatus and method for filtering transactions
GB201918393D0 (en) Safety apparatus and method
MX2019015618A (es) Metodo para medir las caracteristicas de movimiento del cabello.
MX2021003154A (es) Composiciones y métodos para tratar celulitis.
GB2564699B (en) Apparatus and method for generating contact recommendations